Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6153545rdf:typepubmed:Citationlld:pubmed
pubmed-article:6153545lifeskim:mentionsumls-concept:C0684336lld:lifeskim
pubmed-article:6153545lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:6153545lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:6153545lifeskim:mentionsumls-concept:C0682680lld:lifeskim
pubmed-article:6153545lifeskim:mentionsumls-concept:C0006931lld:lifeskim
pubmed-article:6153545lifeskim:mentionsumls-concept:C0038585lld:lifeskim
pubmed-article:6153545lifeskim:mentionsumls-concept:C0015376lld:lifeskim
pubmed-article:6153545lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:6153545pubmed:issue2lld:pubmed
pubmed-article:6153545pubmed:dateCreated1980-5-30lld:pubmed
pubmed-article:6153545pubmed:abstractText1 Rats were pretreated with capsaicin (50 mg/kg, s.c.) on the 2nd, 10th, or 20th day of life. Three months later immunoreactive substance P (I-SP) was determined in skin, sensory nerves and the central nervous system. Neurogenic plasma extravasation was also examined.2 Pretreatment at the age of 2 or 10 days resulted in a decrease (26 to 69%) of I-SP in skin, saphenous and vagus nerve, dorsal roots, dorsal half of the spinal cord, and medulla oblongata. The I-SP content of the ventral half of the spinal cord, of midbrain, hypothalamus, striatum, cortex, and cerebellum remained unchanged. Neurogenic plasma extravasation was inhibited by more than 80%.3 In contrast to this irreversible effect of capsaicin on newborn rats, pretreatment of 20 day old rats led to reversible depletion of I-SP and to reversible impairment of neurogenic plasma extravasation.4 Capsaicin pretreatment of adult rats caused a marked depletion of I-SP in the skin of the hind paw and an impairment of neurogenic plasma extravasation. A similar decrease of I-SP was seen after chronic denervation of the skin.5 Intra-arterial infusion of substance P (threshold dose 5 x 10(-13) mol/min) or physalaemin induced dose-dependent plasma extravasation. Somatostatin, vasoactive intestinal polypeptide, caerulein and the enkephalin-analogue FK 33-824 were ineffective in doses 100 fold higher.6 The results indicate that the action of capsaicin on substance P neurones is restricted to primary sensory neurones. Since in every case a decreased substance P content of the skin was associated with impaired neurogenic plasma extravasation, it is suggested that release of substance P is involved in neurogenic plasma extravasation.lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:languageenglld:pubmed
pubmed-article:6153545pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:citationSubsetIMlld:pubmed
pubmed-article:6153545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6153545pubmed:statusMEDLINElld:pubmed
pubmed-article:6153545pubmed:monthFeblld:pubmed
pubmed-article:6153545pubmed:issn0007-1188lld:pubmed
pubmed-article:6153545pubmed:authorpubmed-author:LembeckFFlld:pubmed
pubmed-article:6153545pubmed:authorpubmed-author:GamseRRlld:pubmed
pubmed-article:6153545pubmed:authorpubmed-author:HolzerPPlld:pubmed
pubmed-article:6153545pubmed:issnTypePrintlld:pubmed
pubmed-article:6153545pubmed:volume68lld:pubmed
pubmed-article:6153545pubmed:ownerNLMlld:pubmed
pubmed-article:6153545pubmed:authorsCompleteYlld:pubmed
pubmed-article:6153545pubmed:pagination207-13lld:pubmed
pubmed-article:6153545pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:meshHeadingpubmed-meshheading:6153545-...lld:pubmed
pubmed-article:6153545pubmed:year1980lld:pubmed
pubmed-article:6153545pubmed:articleTitleDecrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin.lld:pubmed
pubmed-article:6153545pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6153545lld:pubmed
More...